Company / Interest Expense per Share
GYRE THERAPEUTICS, INC. Interest Expense per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.01
FY2023
5-year range
$0.01 / $0.01
FY2022-FY2023
Trend
+19.0%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s interest expense per share of $0.01 is lower than 88% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
0.01 in FY2023.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.01 Sector average $9.80
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 19.0% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.01 | +19.0% |
| FY2022 | $0.01 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026